Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.70
02.05.21
-
02.05.22
1.08%
16.05.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Sartorius AG VZO

Start price
Target price
Perf. (%)
€468.70
16.04.21
€440.00
16.04.22
-18.50%
17.04.22

Probably not worthwhile Investment
Very low/no dividend yield expected
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€73.50
15.04.21
€88.00
15.04.22
10.48%
03.05.21

Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€61.80
08.03.21
-
08.03.22
-21.91%
09.03.22

buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€61.80
08.03.21
-
08.03.22
-26.29%
09.03.22

buy
Stratec SE

Start price
Target price
Perf. (%)
€116.60
03.03.21
€165.00
03.10.22
3.43%
06.04.22

Could be worthwhile Investment >10% per year
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€57.94
01.03.21
-
01.03.22
-2.93%
02.03.22

buy
Vita 34 AG

Start price
Target price
Perf. (%)
€15.55
21.02.21
-
21.02.22
-25.08%
22.02.22

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.22
21.02.21
-
21.02.22
-5.21%
06.03.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€34.83
08.02.21
€41.00
16.07.21
27.92%
16.07.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€33.80
02.02.21
€30.00
16.02.21
0.27%
02.02.21

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.24
01.02.21
€40.00
01.02.22
1.56%
01.02.22

Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.17
01.02.21
€26.00
30.06.22
-10.17%
19.05.22

Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€37.03
29.01.21
€34.00
29.04.21
-5.94%
08.02.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€38.44
27.01.21
€45.00
27.01.22
-4.29%
28.01.22

Could be worthwhile Investment >10% per year
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€67.80
23.01.21
€88.00
23.01.22
-26.99%
24.01.22

Fair valuation
Top 10 in its market
Future proof or reliable business model
Could be worthwhile Investment >10% per year
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€71.80
23.01.21
€88.00
23.01.22
-30.36%
24.01.22

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€69.30
21.01.21
-
21.01.22
17.39%
29.06.21

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€39.13
11.01.21
€50.00
11.01.22
-5.37%
29.01.21

Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
buy
Mediclin AG

Start price
Target price
Perf. (%)
€4.36
10.01.21
€6.00
10.01.22
-15.14%
11.01.22

EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€39.22
04.01.21
€75.00
04.01.22
11.33%
05.09.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
buy
Stratec SE

Start price
Target price
Perf. (%)
€122.40
30.12.20
€128.00
30.12.21
12.75%
31.12.21

Could be worthwhile Investment >10% per year
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€37.29
21.12.20
€42.00
-3.06%
01.02.21

buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.36
13.12.20
-
13.12.21
-5.96%
10.01.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.97
12.11.20
€50.00
12.11.21
21.49%
13.07.21

Top 10 in its market
Small cyclical dependencies
Below average Management